Cargando…

Reconsidering tolerability of cancer treatments: opportunities to focus on the patient

Detalles Bibliográficos
Autores principales:	Peipert, John Devin, Smith, Mary Lou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276550/ https://www.ncbi.nlm.nih.gov/pubmed/35013779 http://dx.doi.org/10.1007/s00520-021-06700-0

Ejemplares similares

Correction to: Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
por: Peipert, John Devin, et al.
Publicado: (2022)

Between-group minimally important change versus individual treatment responders
por: Hays, Ron D., et al.
Publicado: (2021)

Reconsidering the distribution of gray wolves
por: Larson, Greger
Publicado: (2017)

Is It Time to Reconsider How We Initiate Maintenance Dialysis?
por: Arellano-Mendez, Denisse, et al.
Publicado: (2022)

A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition
por: Labanca, Valentina, et al.
Publicado: (2016)

A surplus of positive trials: weighing biases and reconsidering equipoise
por: Felson, David T, et al.
Publicado: (2004)

International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials
por: Brady, Keri J. S., et al.
Publicado: (2023)

Is malaria elimination a distant dream? Reconsidering malaria elimination strategies in Zimbabwe
por: Mbunge, Elliot, et al.
Publicado: (2021)

The place of prenatal visits in pregnancy care: Should we reconsider the current approach?
por: Moise, Mbaluku C., et al.
Publicado: (2023)

It is time to reconsider the unnecessary division of premedical and medical studies
por: Lee, Young-Mee
Publicado: (2018)

Methodological considerations in using patient reported measures in dialysis clinics
por: Peipert, John D., et al.
Publicado: (2017)

Reconsidering the public health failings of the criminal justice system: a reflection on the case of Scott Ortiz
por: Kerr, Thomas
Publicado: (2006)

Bacterial Whack-a-Mole: Reconsidering the Public Health Relevance of Using Carbadox in Food Animals
por: Price, Lance B.
Publicado: (2017)

Reconsidering LINE-1’s role in cancer: does LINE-1 function as a reporter detecting early cancer-associated epigenetic signatures?
por: Kelsey, Maxfield M G
Publicado: (2021)

Time to reconsider urate: Neuroprotective potential may prevail on cardiovascular risk in animal models and clinical trials
por: Petruzzo, Martina, et al.
Publicado: (2018)

High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints
por: Jansen, Anouk M. E., et al.
Publicado: (2023)

The International Polar Year, 2007–2008, An Opportunity to Focus on Infectious Diseases in Arctic Regions
por: Parkinson, Alan J.
Publicado: (2008)

Nitrate-induced tolerance, toxicity and preconditioning: a rationale for reconsidering the use of these drugs
por: Parker, John D, et al.
Publicado: (2009)

Comment on “Should we reframe how we think about physical activity and sedentary behavior measurement? Validity and reliability reconsidered”
por: Terwee, Caroline B., et al.
Publicado: (2016)

Spillover or endemic? Reconsidering the origins of Ebola virus disease outbreaks by revisiting local accounts in light of new evidence from Guinea
por: Fairhead, James, et al.
Publicado: (2021)

How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?
por: Peipert, John Devin, et al.
Publicado: (2022)

Reconsidering syphilis
por: Cameron, A.
Publicado: (2020)

Gestalt Reconsidered
por: Wheeler, Gordon
Publicado: (2013)

Correction to: How do patients interpret and respond to a single‑item global indicator of cancer treatment tolerability?
por: Peipert, John Devin, et al.
Publicado: (2023)

Reconsidering the Share of a Think–Pair–Share: Emerging Limitations, Alternatives, and Opportunities for Research
por: Cooper, Katelyn M., et al.
Publicado: (2021)

Reconsidering Rural-Nonrural College Enrollment Gaps: The Role of Socioeconomic Status in Geographies of Opportunity
por: Wells, Ryan S., et al.
Publicado: (2023)

Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer
por: Addeo, Raffaele
Publicado: (2021)

Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients
por: Chaput, Genevieve, et al.
Publicado: (2023)

Reconsidering the role of language in medicine
por: Franz, Berkeley, et al.
Publicado: (2018)

Behavioral Research in Cancer Prevention and Control: Emerging Challenges and Opportunities
por: Klein, William M P, et al.
Publicado: (2021)

Importance of Patient-Reported Outcome Measures on Clinical Practice in Patients With Kidney Disease
por: Frazier, Rebecca, et al.
Publicado: (2021)

Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
por: Ziogas, Dimitrios C, et al.
Publicado: (2020)

PrEP in Europe – expectations, opportunities and barriers
por: McCormack, Sheena Mary, et al.
Publicado: (2016)

The Whiplash Disease Reconsidered
por: Astrup, Jens, et al.
Publicado: (2022)

Language aptitude reconsidered /
Publicado: (1990)

Robert Boyle reconsidered
por: Brock, William H
Publicado: (1995)

Reconsidering “What Works”
por: Tanner, Kimberly D.
Publicado: (2011)

Reconsidering Visual Search
por: Kristjánsson, Árni
Publicado: (2015)

Reconsidering science learning
por: Scanlon, Eileen, et al.
Publicado: (2004)

Reconsidering conceptual change
por: Limón, Margarita, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_d63o48n9ekfj21b12hd3gd6aug